Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy of an extended injection interval schedule
of lanreotide Autogel 120 mg in acromegalic subjects who are biochemically controlled on long
term treatment with octreotide LAR 10 or 20 mg